Cardiac amyloidosis classification

Jump to navigation Jump to search

Cardiac amyloidosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cardiac Amyloidosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cardiac amyloidosis classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cardiac amyloidosis classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cardiac amyloidosis classification

CDC onCardiac amyloidosis classification

Cardiac amyloidosis classification in the news

Blogs on Cardiac amyloidosis classification

Directions to Hospitals Treating Cardiac amyloidosis

Risk calculators and risk factors for Cardiac amyloidosis classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sabawoon Mirwais, M.B.B.S, M.D.[2]

Overview

Cardiac amyloidosis can be classified based on the type of amyloid that infiltrates the heart. The types of amyloid that commonly deposit in the heart are immunoglobulin light chain (AL) and transthyretin (ATTR). These two types of amyloid can result in cardiac AL amyloidosis and cardiac transthyretin amyloidosis.

Classification

  • Cardiac amyloidosis can be classified based on the type of amyloid that infiltrates the heart.[1][2]
  • The types of amyloid that commonly deposit in the heart are immunoglobulin light chain (AL) transthyretin (ATTR).
  • Based on the above mentioned information, we can classify cardiac amyloidosis into:
  • Cardiac AL amyloidosis
  • Cardiac transthyretin amyloidosis

References

  1. Martinez-Naharro A, Hawkins PN, Fontana M (April 2018). "Cardiac amyloidosis". Clin Med (Lond). 18 (Suppl 2): s30–s35. doi:10.7861/clinmedicine.18-2-s30. PMC 6334035. PMID 29700090.
  2. Quarta CC, Kruger JL, Falk RH (September 2012). "Cardiac amyloidosis". Circulation. 126 (12): e178–82. doi:10.1161/CIRCULATIONAHA.111.069195. PMID 22988049.